Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Key regulatory genes often amplified in aggressive childhood tumor of the brainstem

20.09.2011
Study led by St. Jude Children’s Research Hospital scientists points to possible new treatment targets for diffuse intrinsic pontine gliomas; may tip the scales in the current debate about tumor biopsies

The largest study ever of a rare childhood brain tumor found more than half the tumors carried extra copies of specific genes linked to cancer growth, according to research led by St. Jude Children's Research Hospital investigators.

The findings identify possible new targets for treatment of a tumor in the brainstem known as diffuse intrinsic pontine glioma (DIPG). Current survival rates for children with this cancer are low. Fewer than 10 percent of DIPG patients are alive two years after diagnosis. DIPGs account for 10 to 15 percent of pediatric tumors of the brain and central nervous system.

This study analyzed 43 tumors. Forty-seven percent carried extra copies of genes that transmit signals for cell growth and survival. In 30 percent of tumors, the amplification involved different genes that help control cell division. Twenty-one percent of tumors included genes involved in both mechanisms. The research appears in the September 19 online edition of the Journal of Clinical Oncology.

"Our findings have potential therapeutic relevance and suggest it may be useful to combine drugs that target the pathways disrupted in these tumors both broadly and selectively," said Suzanne Baker, Ph.D., the paper's senior author and member of the St. Jude Department of Developmental Neurobiology.

The work also provided insight into DIPG's origins and added evidence that DIPG is a distinct tumor subtype within a category of brain and spinal tumors known as gliomas. The findings offer the most detailed picture yet of the molecular missteps, including chromosomal changes and altered gene activity, that characterize this tumor.

Efforts to improve patient survival have been hampered in part by limited DIPG samples. "These tumors are one of the most understudied types of cancer because the tumor infiltrates the brainstem, which controls vital functions. It cannot be surgically removed," Baker said. Safety concerns and the accuracy of diagnosis by non-invasive imaging mean that in the U.S. DIPG patients are rarely biopsied.

Baker said these and other research results have prompted renewed discussion about biopsies. "While there may be a rationale for biopsy at diagnosis to determine if specific therapy targets are amplified, our study showed that such amplifications are not always uniformly found within the tumor sample. This suggests that a small biopsy could fail to detect amplification of specific targets, and also that cells within the same tumor may show different responses to selective therapy," she said.

Of the 43 tumors in this study, 37 were donated after autopsy for use in research. Samples of normal tissue were collected as well. Researchers also analyzed other gliomas, including brainstem low-grade gliomas (LGG) and non-brainstem LGG, which occur in the brain outside the brainstem.

Scientists checked for deletions or additions of genetic material at more than 1 million locations across the genome of each tumor. A genome is the complete set of instructions needed to create and sustain a human or other organism. The information is encoded in the DNA molecule, which is packaged into the chromosomes found in nearly every cell.

The screening showed that although DIPGs included extra copies of a variety of genes, two key regulatory mechanisms harbored the most.

Forty-seven percent of DIPGs included extra genes in the receptor tyrosine kinase signaling pathway. This regulatory pathway is disrupted in many tumors and is associated with the unchecked tumor growth and survival that makes cancer deadly. In 30 percent of tumors, the pathway included extra copies of the PDGFRA gene, making it the most commonly amplified gene. Other amplified genes, included MET, IGF1R, ERBB4 and EGFR. In some DIPGs, the pathway included extra copies of more than one of these genes.

Genes that help regulate the cell cycle and cell division were also affected. About 30 percent of DIPGs contained extra copies of the genes that carry instructions for making the Cyclin D family of proteins or the cylin-dependent kinases CDK4 and CDK6.

Chemotherapy agents targeting both pathways are already used to treat other cancers. At St. Jude, a Phase I study is underway using the experimental drug crenolanib to block activity of the PDGFRA protein in DIPGs and related tumors.

When researchers compared gene activity in 27 DIPGs with results from other gliomas found outside the brainstem in both children and adults, they identified significant differences. Baker said those differences offer clues about where DIPGs begin and suggest the HOX family of genes might be involved. "We saw much higher expression of particular HOX gene family members in DIPGs compared to non-brainstem gliomas," she said. This gene family plays an important developmental role in a range of organisms.

The study's first authors are Barbara Paugh, Ph.D., a postdoctoral fellow in Baker's laboratory, and Alberto Broniscer, M.D., associate member of the St. Jude Department of Oncology. Other authors are Chunxu Qu, Claudia Miller, Junyuan Zhang, Ruth Tatevossian, Arzu Onar-Thomas, Justin Baker, Amar Gajjar and David Ellison, all of St. Jude; James Olson and J. Russell Geyer, both of the University of Washington, Seattle; Susan Chi, Dana Farber Cancer Institute, Boston; and Nasjla Saba da Silva, Universidade Federal de Sao Paulo, Brazil.

The research was supported in part by the National Institutes of Health, the National Brain Tumor Society, The Cure Starts Now Foundation, the Smile for Sophie Forever Foundation, Tyler's Treehouse Foundation, Musicians Against Childhood Cancer, the Noyes Brain Tumor Foundation, the Pediatric Low Grade Astrocytoma Foundation and ALSAC.

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering research and treatment of children with cancer and other life-threatening diseases. The hospital's research has helped push overall survival rates for childhood cancer from less than 20 percent when the institution opened to almost 80 percent today. It is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children, and no family ever pays St. Jude for care. For more information, visit www.stjude.org.

Carrie Strehlau | EurekAlert!
Further information:
http://www.stjude.org

Further reports about: Brain DIPG Foundation Oncology cell division gene activity specific gene

More articles from Studies and Analyses:

nachricht The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>